Annual Reports

Quarterly Reports


  • 8-K (Feb 17, 2015)
  • 8-K (Jan 23, 2015)
  • 8-K (Dec 17, 2014)
  • 8-K (Nov 6, 2014)
  • 8-K (Sep 30, 2014)
  • 8-K (Aug 7, 2014)


Volcano 8-K 2007

Documents found in this filing:

  1. 8-K
  2. 8-K

Washington, D.C. 20549
Form 8-K
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 23, 2007
Volcano Corporation
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)
(I.R.S. Employer
Identification No.)
2870 Kilgore Road
Rancho Cordova, California

(Address of principal
executive offices)

(Zip Code)
(800) 228-4728
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
     (b) On April 23, 2007, Robert J. Adelman, M.D. provided notice to the board of directors (the “Board”) of Volcano Corporation (the “Company”) of his intent not to stand for reelection at the Company’s 2007 annual meeting of stockholders. Currently, Dr. Adelman serves in the class of directors whose term of office expires at the Company’s 2007 annual meeting of stockholders and serves on the Audit Committee of the Board (the “Audit Committee”). Dr. Adelman’s intent not to stand for reelection is not the result of a disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
     (d) On April 26, 2007, the Corporate Governance Committee of the Board recommended to the Board, and the Board subsequently approved, the election of Connie J. Curran, RN, Ed.D. to fill the vacancy created by the previously reported resignation of S. Ward Casscells, M.D. from the Board, and to serve on the Board and the Audit Committee until the Company’s 2008 annual meeting of stockholders and until her successor is duly elected and qualified, or until her earlier resignation or removal. In accordance with the Company’s Stock Option Grant Program for Non-Employee Directors administered under the Company’s 2005 Equity Compensation Plan (the “2005 Plan”), the Board granted Dr. Curran a nonstatutory stock option under the 2005 Plan to purchase 20,000 shares of the Company’s common stock, subject to the terms and conditions approved by the Board.
     The Company also entered into a standard form of indemnity agreement with Dr. Curran (the “Indemnity Agreement”). The Indemnity Agreement provides, among other things, that the Company will indemnify Dr. Curran, under the circumstances and to the extent provided for therein, for certain expenses which she may be required to pay in connection with certain claims to which she may be made a party by reason of her position as a director of the Company, and otherwise to the fullest extent permitted under Delaware law and the Company’s Bylaws.
     The Company’s standard form of indemnity agreement was previously filed as Exhibit 10.1 to the Company’s Registration Statement on Form S-1, as amended, as filed on March 24, 2006, and is incorporated herein by reference.



     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
  Volcano Corporation
  By:   /s/ John T. Dahldorf    
    John T. Dahldorf   
    Chief Financial Officer   
Date: April 27, 2007


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki